drugset / Trial / NCT02264158
Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
Assessment of the influence of telmisartan, lacidipine and their combination on the QTC interval of the ECG
Timeline
- Start
- 2001-09
- Primary completion
- 2002-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lacidipine | Small molecule | 4 mg | Oral |
| Comparator | Lacidipine | Small molecule | 6 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 40 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 160 mg | Oral |
Indications
No indication recorded.